Radiant Innovation

Radiant Innovation R&D Expenses

The Research & Development Expenses of Radiant Innovation (3373.TWO) as of Nov 20, 2026 is 61.74 M TWD. In the previous year, Research & Development Expenses was 62.18 M TWD — a change of -0.71% (lower).

R&D Expenses

61.74 MTWD

YoY

-0.71%

Last updated:

Research & Development Expenses of Radiant Innovation is 2025 61.74 M TWD. Research & Development Expenses of Radiant Innovation was 2024 62.18 M TWD. It decreases by -0.71% lower compared to the previous year.

The Radiant Innovation R&D Expenses history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

R&D Expenses
Date
R&D Expenses
Jan 1, 2018
68.32 M TWD
Jan 1, 2019
69.92 M TWD
Jan 1, 2020
132.28 M TWD
Jan 1, 2021
65.08 M TWD
Jan 1, 2022
61.88 M TWD
Jan 1, 2023
66.14 M TWD
Jan 1, 2024
62.18 M TWD
Jan 1, 2025
61.74 M TWD
The Radiant Innovation R&D Expenses history
YEARR&D ExpensesYoY
61.74 MTWD-0.71%
62.18 MTWD-5.99%
66.14 MTWD+6.89%
61.88 MTWD-4.92%
65.08 MTWD-50.81%
132.28 MTWD+89.19%
69.92 MTWD+2.35%
68.32 MTWD-2.53%
70.09 MTWD+1.04%
69.37 MTWD-6.33%
74.05 MTWD+25.08%
59.20 MTWD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Radiant Innovation Stock analysis

What does Radiant Innovation do? Radiant Innovation Inc. generates revenue through the design, manufacture, and sale of infrared technology products. The company's main products include infrared temperature measurement instruments, ear temperature guns, frontal temperature guns, and other body temperature measurement products, alongside carbon dioxide detectors, infrared thermal imagers, and blood glucose dedicated chipsets. These products are distributed domestically and internationally across Asia, the Americas, Europe, and other regions. The primary buyers are healthcare providers, medical facilities, and electronic component distributors who require precise measurement tools and specialized components for health monitoring and diagnostics. The firm's product portfolio targets healthcare and industrial segments, with infrared thermal imagers used in building inspections and carbon dioxide detectors deployed in environmental monitoring. Blood glucose dedicated chipsets are supplied to medical device manufacturers for integration into diagnostic equipment. International distribution channels focus on regions like Asia, the Americas, and Europe, where demand for health-related measurement devices remains strong. Revenue streams are driven by direct sales to medical institutions, electronic component distributors, and industrial clients. The company's product lines serve both consumer-facing health monitoring applications and specialized industrial uses, with a strong emphasis on accuracy and reliability in temperature and gas detection technologies. Radiant Innovation is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Radiant Innovation stock

Research & Development Expenses of Radiant Innovation is 61.74 M TWD in 2025.

Research & Development Expenses of Radiant Innovation changed from 62.18 M TWD to 61.74 M TWD, representing a -0.71% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Research & Development Expenses Radiant Innovation since 2006 – with annual values, charts, and detailed analysis.

R&D expenses represent the costs incurred in researching and developing new products, services, or processes. High R&D spending can signal innovation and future growth potential.

Research & Development Expenses's TWD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Research & Development Expenses's Radiant Innovation historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Income Statement — Radiant Innovation

All Key Metrics — Radiant Innovation